Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2003
05/13/2003US6562840 Heteroaryl amidines, methylamidines and guanidines, and the use thereof as protease inhibitors
05/13/2003US6562827 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages
05/13/2003US6562815 Morpholinones as light stabilizers
05/13/2003US6562813 Aralkyl and aralkylidene heterocyclic lactams and imides
05/13/2003US6562811 Pyridine derivatives
05/13/2003US6562808 Calcium channel antagonists effective in treating intestinal diseases caused by abnormal acceleration of the contraction of intestinal tracts such as irritable bowel syndrome, without significant cardiac effects
05/13/2003US6562792 Hygromycin derivatives
05/13/2003CA2127876C Imidazole derivatives and their use as cytokine inhibitors
05/08/2003WO2003037916A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003WO2003037894A1 4-(5-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
05/08/2003WO2003037892A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003WO2003037890A2 Piperidines
05/08/2003WO2003037888A1 3-substituted-4-pyrimidone derivatives
05/08/2003WO2003037887A1 Therapeutic isoquinoline compounds
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003WO2003037869A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003WO2003037862A1 Amide derivatives and drugs
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2003037332A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003WO2003037328A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
05/08/2003WO2003037327A1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors
05/08/2003WO2003037274A2 Pyrazole-amides and-sulfonamides
05/08/2003WO2003037271A2 Compounds, pharmaceutical compositions and methods of use therefor
05/08/2003WO2002060897A3 Process for making substituted 8-arylquinolinium benzenesulfonate
05/08/2003US20030088103 PPARgamma modulators
05/08/2003US20030087945 Sulfonylaminocarboxylic acids
05/08/2003US20030087935 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
05/08/2003US20030087928 Novel anilide compounds and drugs containing the same
05/08/2003US20030087925 Benzoamide piperidine containing compounds and related compounds
05/08/2003US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines
05/08/2003US20030087919 Rho-kinase inhibitors
05/08/2003US20030087909 Having an attached non-aromatic heterocyclic ring
05/08/2003US20030087907 Quinoline derivatives and quinazoline derivatives having azolyl group
05/08/2003US20030087902 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents
05/08/2003US20030087901 Compounds and methods for modulation of estrogen receptors
05/08/2003US20030087892 Condensed azepines as vasopressin agonists
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003CA2465350A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003CA2465344A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003CA2464944A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003CA2464353A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003CA2464342A1 Therapeutic isoquinoline compounds
05/08/2003CA2463821A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003CA2463770A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003CA2463441A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003CA2462206A1 Substituted thioacetamides
05/07/2003EP1308439A1 Proline derivatives and use thereof as drugs
05/07/2003EP1308084A1 Synergistic UV absorber combination
05/07/2003EP1307579A2 Bio-intermediates for use in the chemical synthesis of polyketides
05/07/2003EP1307460A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
05/07/2003EP1307204A1 Protease inhibitors
05/07/2003EP1214316B1 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
05/07/2003EP0869791B1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
05/07/2003EP0858464B1 Thrombin inhibitors
05/07/2003EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/07/2003EP0730738B1 Metal chelate containing compositions for use in chemiluminescent assays
05/07/2003CN1416429A Pyrimidine derivatives having antitumor effect
05/07/2003CN1416424A Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase
05/07/2003CN1416423A 2,4,Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
05/07/2003CN1107671C Imide derivatives
05/07/2003CN1107505C Synergistic combination of AIDS antiviral compounds and HIV inhibitor
05/06/2003US6559173 organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
05/06/2003US6559162 Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
05/06/2003US6559144 Integrin inhibitors used to treat circulatory disorders, for thrombosis, myocardial infarct, coronary heart disease, arteriosclerosis, osteoporosis, pathological processes maintained or propagated by angiogenesis and tumor therapy
05/06/2003US6559140 Cyclic and bicyclic diamino histamine-3 receptor antagonists
05/02/2003EP1306377A2 Pyridyl-oxazoles and their use as cytokines inhibitors
05/02/2003EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/02/2003EP1305319A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/02/2003EP1305309A1 Lactam inhibitors of factor xa which are useful for the treatment of thrombosis
05/02/2003EP1305308A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
05/02/2003EP1305303A1 NOVEL FORM OF (R)- i N /i - 5-METHYL-8-(4-METHYLPIPERAZIN-1-YL)-1,2,3,4-TETRAHYDRO-2-NAPHTHYL]-4-MORPHOLINOBENZAMIDE
05/02/2003EP1305300A1 Novel, slow-acting betamimetics, a method for their production and their use as medicaments
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305291A1 3-substituted isoquinolin-1-yl derivatives
05/02/2003EP1305270A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
05/02/2003EP1305048A2 Inhibitors of cellular efflux pumps of microbes
05/02/2003EP1196167A4 Method of reducing neuronal injury or apoptosis
05/02/2003EP1045846B1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
05/02/2003EP1037886B1 Triazine angiogenesis inhibitors
05/02/2003EP0966452B1 Process for preparing sulphurous 2-chloro-3-(4,5-dihydroisoxazol-3-yl)-benzoic acids
05/01/2003WO2003035735A1 Low color, low sodium benzoxazinone uv absorbers and process for making same
05/01/2003WO2003035645A1 Novel 4-(2-furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
05/01/2003WO2003035644A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003WO2003035621A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
05/01/2003WO2003035620A1 Bicyclic compound
05/01/2003WO2003035615A2 Tyrosine kinase inhibitors
05/01/2003WO2003035133A1 Stents
05/01/2003WO2003035077A1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
05/01/2003WO2003035076A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
05/01/2003WO2003035073A1 Isoxazoline derivatives useful as antimicrobials
05/01/2003WO2003035066A1 2-aminoquinolone derivatives for use as impdh inhibitors
05/01/2003WO2003035065A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
05/01/2003WO2003005824A3 Substituted 3-heteroaryl (amino-or-oxy)-pyrrolidin-2-ones, method for the production thereof and use thereof as herbicides or as plant growth regulators
05/01/2003WO2002081478A3 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
05/01/2003WO2002076438A3 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
05/01/2003WO2002038553A3 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists
05/01/2003US20030083345 Method of treatment and/or prevention of brain, spinal or nerve injury
1 ... 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 ... 647